AMR Industry alliance third progress report

  01 February 2022

The AMR Industry Alliance’s Progress Report reflects on collective achievements from the life sciences industry to minimize the spread of antimicrobial resistance (AMR). Findings from the leading coalition of biotechnology, diagnostics, generic and large research-based pharmaceutical companies indicate continued focus and leadership from the life sciences sector. Industry is helping to shape a positive future outlook in the fight against AMR but continued cross-sector collaborations along with policy and regulatory changes toward a more sustainable marketplace are needed. The report’s findings represent collective results from across Alliance membership on their current AMR activities related to research and science, access, appropriate use, and manufacturing and the environment.  The report was conducted by RAND Europe.

Further reading: AMR Industry Alliance
Author(s): AMR Industry Alliance
Clean Environment   Effective Surveillance   Healthy Patients   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!